Flumazenil Injection, Solution
Product Images NDC 0404-9793

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Flumazenil (NDC 0404-9793). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Henry Schein, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Formula1.jpg (Formula1)

FDA Label Image

Image1.jpg (Image1)

Image1.jpg (Image1)
This text discusses the magnitude and duration of the reversal of sedation based on different doses of Flumazenil (0.2 mg, 0.6 mg, and 1 mg) and their corresponding blood levels in ng/mL. The study involved healthy volunteers receiving Flumazenil at a dosage rate of 0.06-0.20 mg/kg/hr, resulting in complete alertness.*
FDA Label Image

Image2.jpg (Image2)

Image2.jpg (Image2)
This text provides pharmacokinetic data for a substance, including Crax concentration in ng/mL, AUC in ng-hr/mL, Vss in L/kg, Cl in L/hr/kg, and Half-life in minutes. The percentages and corresponding ranges are also given for different parameters.*
FDA Label Image

Image3.jpg (Image3)

Image3.jpg (Image3)
Flumazenil usage should be monitored closely as it has been linked to seizures, particularly in patients on long-term benzodiazepines or in overdose cases involving serious cyclic antidepressant overdose. Practitioners are advised to adjust flumazenil dosage on a case-by-case basis and be ready to handle any resulting seizures.*
FDA Label Image

Label1.jpg (Label1jpg)

Label1.jpg (Label1jpg)
This is a description of Flumazenil injection, USP with a concentration of 0.1 mg/ml in a 5mL vial for intravenous use only. The medication should be stored between 15 to 30 degrees Celsius and out of children's reach. It is manufactured by Hikma Farmaceutica (Portugal), S.A. and distributed by Henry Schein, Inc. under the item number 2580470. Prescription use only.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.